Sputnik
Ralph Bartenschlager, president of the German Society of Virologists, admitted that adenovirus-based vaccines, such as the Russian “Sputnik V”, are easier to transfer than RNA vaccines.
He pointed out that the transfer of vaccines based on messenger RNA, such as those from Pfizer / BioNTech and Moderna, can only be done at extremely low temperatures.
“In countries like Germany, there are no serious problems with transporting existing RNA vaccines, because DHL and Lufthansa have enough cooling blocks to be able to transport the vaccine at minus 70 degrees,” said Ralph Bartenschlager.
He noted that there are many countries that do not have this capability, and this means that they cannot use RNA vaccines, at least in their current form. He said: “These countries in particular can rely on adenovirus vaccine that does not require severe cooling.
Source: Novosti